NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 32 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | -80.0% | 90,000 | -52.9% | 0.01% | -74.4% |
| Q1 2022 | $80,000 | -29.8% | 191,028 | 0.0% | 0.04% | +7.5% |
| Q4 2021 | $114,000 | -49.8% | 191,028 | 0.0% | 0.04% | -11.1% |
| Q3 2021 | $227,000 | -12.0% | 191,028 | 0.0% | 0.04% | +9.8% |
| Q2 2021 | $258,000 | -18.6% | 191,028 | 0.0% | 0.04% | -28.1% |
| Q1 2021 | $317,000 | – | 191,028 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 45,849 | $27,000 | 1.56% |
| Aisling Capital Management LP | 191,028 | $114,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 357,481 | $214,000 | 0.03% |
| FRAZIER MANAGEMENT LLC | 425,650 | $255,000 | 0.02% |
| Values First Advisors, Inc. | 38,386 | $23,000 | 0.01% |
| Virtu Financial LLC | 209,443 | $125,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 67,051 | $40,000 | 0.01% |
| CCG WEALTH MANAGEMENT, LLC | 10,000 | $6,000 | 0.00% |
| XR Securities LLC | 10,800 | $21,000 | 0.00% |
| HAP Trading, LLC | 23,300 | $34,000 | 0.00% |